Deep radiomic signature with immune cell markers predicts the survival of glioma patients

• URL: http://arxiv.org/abs/2206.04349v1
• Date: Thu, 9 Jun 2022 08:52:15 GMT
• Title: Deep radiomic signature with immune cell markers predicts the survival of glioma patients
• Authors: Ahmad Chaddad, Paul Daniel Mingli Zhang, Saima Rathore, Paul Sargos, Christian Desrosiers, Tamim Niazi
• Abstract summary: We propose a novel type of deep radiomic features (DRFs) computed from a convolutional neural network (CNN) The proposed method extracts a total of 180 DRFs by aggregating the activation maps of a pre-trained 3D-CNN within labeled tumor regions of MRI scans. Results show a high correlation between DRFs and various markers, as well as significant differences between patients grouped based on these markers.
• Score: 8.386631203775533
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Imaging biomarkers offer a non-invasive way to predict the response of immunotherapy prior to treatment. In this work, we propose a novel type of deep radiomic features (DRFs) computed from a convolutional neural network (CNN), which capture tumor characteristics related to immune cell markers and overall survival. Our study uses four MRI sequences (T1-weighted, T1-weighted post-contrast, T2-weighted and FLAIR) with corresponding immune cell markers of 151 patients with brain tumor. The proposed method extracts a total of 180 DRFs by aggregating the activation maps of a pre-trained 3D-CNN within labeled tumor regions of MRI scans. These features offer a compact, yet powerful representation of regional texture encoding tissue heterogeneity. A comprehensive set of experiments is performed to assess the relationship between the proposed DRFs and immune cell markers, and measure their association with overall survival. Results show a high correlation between DRFs and various markers, as well as significant differences between patients grouped based on these markers. Moreover, combining DRFs, clinical features and immune cell markers as input to a random forest classifier helps discriminate between short and long survival outcomes, with AUC of 72\% and p=2.36$\times$10$^{-5}$. These results demonstrate the usefulness of proposed DRFs as non-invasive biomarker for predicting treatment response in patients with brain tumors.

Related papers

• TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs [49.69047720285225]
  We propose a novel topological approach that explicitly extracts multi-scale topological structures to better approximate breast parenchymal structures. We empirically validate emphTopoTxR using the VICTRE phantom breast dataset. Our qualitative and quantitative analyses suggest differential topological behavior of breast tissue in treatment-na"ive imaging.
  arXiv  Detail & Related papers  (2024-11-05T19:35:10Z)
• UMambaAdj: Advancing GTV Segmentation for Head and Neck Cancer in MRI-Guided RT with UMamba and nnU-Net ResEnc Planner [0.04924932828166548]
  Magnetic Resonance Imaging (MRI) plays a crucial role in adaptive radiotherapy for head and neck cancer (HNC) due to its superior soft-tissue contrast. accurately segmenting the gross tumor volume (GTV), which includes both the primary tumor (GTVp) and lymph nodes (GTVn) remains challenging. Recently, two deep learning segmentation innovations have shown great promise: UMamba, which effectively captures long-range dependencies, and the nnU-Net Residual (ResEnc) which enhances feature extraction through multistage residual blocks.
  arXiv  Detail & Related papers  (2024-10-16T18:26:27Z)
• Brain Tumor Segmentation (BraTS) Challenge 2024: Meningioma Radiotherapy Planning Automated Segmentation [47.119513326344126]
  The BraTS-MEN-RT challenge aims to advance automated segmentation algorithms using the largest known multi-institutional dataset of radiotherapy planning brain MRIs. Each case includes a defaced 3D post-contrast T1-weighted radiotherapy planning MRI in its native acquisition space. Target volume annotations adhere to established radiotherapy planning protocols.
  arXiv  Detail & Related papers  (2024-05-28T17:25:43Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Brain Tumor Recurrence vs. Radiation Necrosis Classification and Patient Survivability Prediction [0.0]
  GBM is the most aggressive brain tumor in adults that has a short survival rate even after aggressive treatment with surgery and radiation therapy. The changes on magnetic resonance imaging (MRI) for patients with GBM after radiotherapy are indicative of radiation-induced necrosis (RN) or recurrent brain tumor (rBT) This study proposes computational modeling with statistically rigorous repeated random sub-sampling to balance the subset sample size for rBT and RN classification.
  arXiv  Detail & Related papers  (2023-06-05T21:39:11Z)
• Cancer-Net BCa-S: Breast Cancer Grade Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging [82.74877848011798]
  The prevalence of breast cancer continues to grow, affecting about 300,000 females in the United States in 2023. The gold-standard Scarff-Bloom-Richardson (SBR) grade has been shown to consistently indicate a patient's response to chemotherapy. In this paper, we study the efficacy of deep learning for breast cancer grading based on synthetic correlated diffusion (CDI$s$) imaging.
  arXiv  Detail & Related papers  (2023-04-12T15:08:34Z)
• Modeling of Textures to Predict Immune Cell Status and Survival of Brain Tumour Patients [4.542148087324063]
  Radiomics has shown a capability for different types of cancers such as glioma to predict the clinical outcome. We aim to predict the immune marker status (low versus high) and overall survival for glioma patients using deep radiomic features (DRFs) Our experiments are performed to assess the relationship between the proposed DRFs, three immune cell markers (Macrophage M1, Neutrophils and T Cells Follicular Helper) and measure their association with overall survival.
  arXiv  Detail & Related papers  (2022-06-04T03:52:12Z)
• Severity classification in cases of Collagen VI-related myopathy with Convolutional Neural Networks and handcrafted texture features [0.34998703934432684]
  Three methods are proposed to classify target muscles in Collagen VI-related myopathy cases. The best results were obtained with the hybrid model, resulting in a global accuracy of 93.8%.
  arXiv  Detail & Related papers  (2022-02-28T15:09:42Z)
• A New Deep Hybrid Boosted and Ensemble Learning-based Brain Tumor Analysis using MRI [0.28675177318965034]
  Two-phase deep learning-based framework is proposed to detect and categorize brain tumors in magnetic resonance images (MRIs) In the first phase, a novel deep boosted features and ensemble classifiers (DBF-EC) scheme is proposed to detect tumor MRI images from healthy individuals effectively. In the second phase, a new hybrid features fusion-based brain tumor classification approach is proposed, comprised of dynamic-static feature and ML classifier to categorize different tumor types.
  arXiv  Detail & Related papers  (2022-01-14T10:24:47Z)
• EMT-NET: Efficient multitask network for computer-aided diagnosis of breast cancer [58.720142291102135]
  We propose an efficient and light-weighted learning architecture to classify and segment breast tumors simultaneously. We incorporate a segmentation task into a tumor classification network, which makes the backbone network learn representations focused on tumor regions. The accuracy, sensitivity, and specificity of tumor classification is 88.6%, 94.1%, and 85.3%, respectively.
  arXiv  Detail & Related papers  (2022-01-13T05:24:40Z)
• Controlling False Positive/Negative Rates for Deep-Learning-Based Prostate Cancer Detection on Multiparametric MR images [58.85481248101611]
  We propose a novel PCa detection network that incorporates a lesion-level cost-sensitive loss and an additional slice-level loss based on a lesion-to-slice mapping function. Our experiments based on 290 clinical patients concludes that 1) The lesion-level FNR was effectively reduced from 0.19 to 0.10 and the lesion-level FPR was reduced from 1.03 to 0.66 by changing the lesion-level cost.
  arXiv  Detail & Related papers  (2021-06-04T09:51:27Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.